MSFT
44
3
TSN
43
-3
KO
46
-11
EIX
45
-8
BRK.B
40
-3
EXC
50
-3
NWSA
62
-4
EMC
80
20
SBUX
36
-4
MRK
58
-2
PHM
54
-3
ROK
60
-2
CAT
73
-3
MTB
71
2
ABT
36
-3
SRE
54
-3
CI
40
-2
LMT
57
7
NWL
54
-3
UA
26
-4
MSFT
44
3
TSN
43
-3
KO
46
-11
EIX
45
-8
BRK.B
40
-3
EXC
50
-3
NWSA
62
-4
EMC
80
20
SBUX
36
-4
MRK
58
-2
PHM
54
-3
ROK
60
-2
CAT
73
-3
MTB
71
2
ABT
36
-3
SRE
54
-3
CI
40
-2
LMT
57
7
NWL
54
-3
UA
26
-4
Financhill
Back

Cleveland-Cliffs, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Sell
36

CLF
Cleveland-Cliffs, Inc.

Last Price:
$12.33
Seasonality Move:
8.94%
Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$68.70
Seasonality Move:
-31.39%
Sell
36
Cleveland-Cliffs, Inc. (CLF) is a Sell

Is Cleveland-Cliffs, Inc. a Buy, Sell or Hold?

  • The current Cleveland-Cliffs, Inc. [CLF] share price is $12.37. The Score for CLF is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • CLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CLF Stock Price Chart

What is Cleveland-Cliffs, Inc.'s stock price today?

  • The Cleveland-Cliffs, Inc. share price today is $12.37
    The current trend is moderately bullish and CLF is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $69.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.

CLF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.21 Buy
Relative Strength Index (14 RSI): 52.75 Buy
Chaikin Money Flow: 7323511 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.55 - 12.51) Buy
Bollinger Bands (100): (10.27 - 12.95) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.48 Buy
Relative Strength Index (14 RSI): 86.01 Buy
Chaikin Money Flow: 124529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.63 - 42.89) Buy
Bollinger Bands (100): (18.11 - 33.75) Buy

CLF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.73 Sell
20-day SMA: 11.73 Buy
50-day SMA: 12.44 Sell
200-day SMA: 9.92 Buy
8-day EMA: 12.47 Sell
20-day EMA: 12.17 Buy
50-day EMA: 11.99 Buy
200-day EMA: 11.09 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.22 Buy
20-day SMA: 36.44 Buy
50-day SMA: 32.1 Buy
200-day SMA: 23.71 Buy
8-day EMA: 41.78 Buy
20-day EMA: 37.11 Buy
50-day EMA: 32.59 Buy
200-day EMA: 27.3 Buy

Cleveland-Cliffs, Inc. Earnings Growth & CLF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.59 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.72 per share, and an increase next year of $2.66 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.

Cleveland-Cliffs, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):